Literature DB >> 18722816

Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.

Stefanie Kuerten1, Sita Javeri, Magdalena Tary-Lehmann, Paul V Lehmann, Doychin N Angelov.   

Abstract

Multiple sclerosis (MS) is characterized by a dynamic inflammatory process in which CNS lesions of distinct cellular composition coexist. In particular the formation of B cell plaques has been ascribed an important role as predictor of disease progression. Here we show that the novel MBP-PLP fusion protein (MP4)-induced experimental autoimmune encephalomyelitis (EAE) of C57BL/6 mice fulfils these criteria inducing differential cellular infiltration of B cells, T cells, macrophages and granulocytes and permitting the quantification and staging of the disease. On the contrary, both key features - dynamic CNS inflammation and B cell infiltration - were absent in the classical MOG:35-55-induced EAE of C57BL/6 mice, which was characterized by a static CD4(+) T cell and macrophage-mediated CNS immunopathology throughout the disease. MP4-induced EAE may thus provide a unique opportunity for studying immune-pathomechanisms of the disease that have been previously neglected due to experimental shortcomings in murine EAE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722816      PMCID: PMC2590643          DOI: 10.1016/j.clim.2008.07.016

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  51 in total

1.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

2.  MBP-PLP fusion protein-induced EAE in C57BL/6 mice.

Authors:  Stefanie Kuerten; Felix S Lichtenegger; Susan Faas; Doychin N Angelov; Magdalena Tary-Lehmann; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2006-06-15       Impact factor: 3.478

Review 3.  The origin and application of experimental autoimmune encephalomyelitis.

Authors:  Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2007-11       Impact factor: 53.106

4.  MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Authors:  Stefanie Kuerten; Dilyana A Kostova-Bales; Lukas P Frenzel; Justine T Tigno; Magdalena Tary-Lehmann; Doychin N Angelov; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2007-07-25       Impact factor: 3.478

Review 5.  Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis.

Authors:  J Goverman; T Brabb
Journal:  Lab Anim Sci       Date:  1996-10

Review 6.  Immunology of multiple sclerosis.

Authors:  Mireia Sospedra; Roland Martin
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 7.  Candidate autoantigens in multiple sclerosis.

Authors:  S Schmidt
Journal:  Mult Scler       Date:  1999-06       Impact factor: 6.312

8.  Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.

Authors:  T Berger; S Weerth; K Kojima; C Linington; H Wekerle; H Lassmann
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

9.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

10.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Authors:  Roberta Magliozzi; Owain Howell; Abhilash Vora; Barbara Serafini; Richard Nicholas; Maria Puopolo; Richard Reynolds; Francesca Aloisi
Journal:  Brain       Date:  2007-04       Impact factor: 13.501

View more
  9 in total

1.  IL-3 promotes the development of experimental autoimmune encephalitis.

Authors:  Kerstin Renner; Sonja Hellerbrand; Fabian Hermann; Christine Riedhammer; Yvonne Talke; Gabriela Schiechl; Manuel Rodriguez Gomez; Simone Kutzi; Dagmar Halbritter; Nicole Goebel; Hilke Brühl; Robert Weissert; Matthias Mack
Journal:  JCI Insight       Date:  2016-10-06

2.  Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Sajad Emami Aleagha; Mohammad Hossein Harirchian; Shahram Lavasani; Mohammad Javan; Abdolamir Allameh
Journal:  J Mol Neurosci       Date:  2018-03-14       Impact factor: 3.444

3.  Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.

Authors:  Johanna Prinz; Aylin Karacivi; Eva R Stormanns; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

4.  Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.

Authors:  Ganta Vijay Chaitanya; Seiichi Omura; Fumitaka Sato; Nicholas E Martinez; Alireza Minagar; Murali Ramanathan; Bianca Weinstock Guttman; Robert Zivadinov; Ikuo Tsunoda; Jonathan S Alexander
Journal:  J Neuroinflammation       Date:  2013-10-14       Impact factor: 8.322

5.  CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.

Authors:  Damiano M Rovituso; Laura Scheffler; Marie Wunsch; Christoph Kleinschnitz; Sebastian Dörck; Jochen Ulzheimer; Antonios Bayas; Lawrence Steinman; Süleyman Ergün; Stefanie Kuerten
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

6.  Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.

Authors:  Georgina Galicia; Bryant Boulianne; Natalia Pikor; Alberto Martin; Jennifer L Gommerman
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

7.  Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.

Authors:  Andreas Arndt; Peter Hoffacker; Konstantin Zellmer; Oktay Goecer; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

8.  Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.

Authors:  Thomas Breakell; Sabine Tacke; Verena Schropp; Henrik Zetterberg; Kaj Blennow; Eduard Urich; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

9.  Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis.

Authors:  Sabine Tacke; Rittika Chunder; Verena Schropp; Eduard Urich; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.